ALDAGEN - Press Releases

............................................................................................................................................

Press Releases Archives: 2008, 2007, 2006, 2005

04.06.09

Stem cell therapy grows new blood vessels

11.20.08

Aldagen announces positive results for ALD-301

11.05.08

Aldagen and UC Davis form Collaboration

10.30.08

Aldagen Receives Orphan Drug Designation for ALD-101

10.15.08

Aldagen Appoints Hohnke to Board

07.22.08

Aldagen Appoints Evans to Board

5.12.08

Aldagen Files Registration Statement for Initial Public Offering

4.23.08

Aldagen Secures $18.4 Million in Financing

4.15.08

Aldagen Announces Initiation of ALD-101 Phase III Trial for Improving Cord Blood Transplants in Pediatric Patients with Inherited Metabolic Diseases

3.03.08

Aldagen Announces Appointment of David P. Carberry as Chief Financial Officer

1.23.08

Aldagen to Present at Leerink Swann and Wachovia Investor Conferences